盈康生命
(300143)
| 流通市值：65.48亿 | | | 总市值：76.52亿 |
| 流通股本：6.41亿 | | | 总股本：7.49亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,559,238,250.45 | 1,227,709,136.74 | 823,222,466.04 | 416,230,884.39 |
| 营业收入 | 1,559,238,250.45 | 1,227,709,136.74 | 823,222,466.04 | 416,230,884.39 |
| 二、营业总成本 | 1,423,464,120.76 | 1,121,158,642.67 | 754,772,394.67 | 382,865,011.79 |
| 营业成本 | 1,155,960,792.06 | 906,559,106.89 | 604,820,945.84 | 304,853,668.78 |
| 税金及附加 | 3,577,165.76 | 2,720,655.51 | 1,859,382.65 | 779,771.37 |
| 销售费用 | 52,998,815.75 | 44,109,259.88 | 31,508,030.67 | 17,094,740.99 |
| 管理费用 | 155,449,831.96 | 128,320,176.19 | 91,033,669.65 | 46,917,988.88 |
| 研发费用 | 54,522,538.13 | 36,844,629.34 | 25,057,697.42 | 13,073,292.94 |
| 财务费用 | 954,977.1 | 2,604,814.86 | 492,668.44 | 145,548.83 |
| 其中:利息费用 | 11,937,925.65 | 8,387,688.79 | 5,670,529.72 | 3,493,293.39 |
| 其中:利息收入 | 10,175,994.84 | 7,409,215.23 | 4,929,599.67 | 3,500,498.07 |
| 加:公允价值变动收益 | -5,469,481.61 | 0 | - | - |
| 加:投资收益 | 861,772.62 | 720,440.44 | 666,712.56 | 28,580.82 |
| 净敞口套期收益 | - | 0 | - | - |
| 汇兑收益 | - | 0 | - | - |
| 资产处置收益 | 503,414.76 | 319,822.34 | 299,814.65 | 297,314.63 |
| 资产减值损失(新) | -4,065,288.46 | -76,677.54 | -238,353.26 | - |
| 信用减值损失(新) | -20,053,952 | -6,021,747.42 | -2,110,890.41 | -3,026,574.95 |
| 其他收益 | 20,442,910.12 | 12,713,557.7 | 8,685,539.18 | 4,036,382.07 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 127,993,505.12 | 114,205,889.59 | 75,752,894.09 | 34,701,575.17 |
| 加:营业外收入 | 27,523,265.35 | 1,205,726.45 | 285,181.23 | 143,384.65 |
| 减:营业外支出 | 6,251,466.41 | 4,196,947.28 | 2,909,837.57 | 672,261.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 149,265,304.06 | 111,214,668.76 | 73,128,237.75 | 34,172,697.88 |
| 减:所得税费用 | 33,279,451.63 | 28,014,887.72 | 18,878,286.29 | 8,115,539.45 |
| 六、净利润 | 115,985,852.43 | 83,199,781.04 | 54,249,951.46 | 26,057,158.43 |
| 持续经营净利润 | 115,985,852.43 | 83,199,781.04 | 54,249,951.46 | 26,057,158.43 |
| 终止经营净利润 | - | 0 | - | - |
| 归属于母公司股东的净利润 | 115,423,812.48 | 82,544,665.51 | 54,801,148.25 | 26,225,857.82 |
| 少数股东损益 | 562,039.95 | 655,115.53 | -551,196.79 | -168,699.39 |
| (一)基本每股收益 | 0.18 | 0.13 | 0.09 | 0.04 |
| (二)稀释每股收益 | 0.18 | 0.13 | 0.09 | 0.04 |
| 八、其他综合收益 | -43,638.67 | -64,371.68 | 13,864.67 | 10,995.46 |
| 归属于母公司股东的其他综合收益 | -43,638.67 | -64,371.68 | 13,864.67 | 10,995.46 |
| 九、综合收益总额 | 115,942,213.76 | 83,135,409.36 | 54,263,816.13 | 26,068,153.89 |
| 归属于母公司股东的综合收益总额 | 115,380,173.81 | 82,480,293.83 | 54,815,012.92 | 26,236,853.28 |
| 归属于少数股东的综合收益总额 | 562,039.95 | 655,115.53 | -551,196.79 | -168,699.39 |
| 公告日期 | 2025-03-29 | 2024-10-28 | 2024-08-23 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |